Building Phase-Appropriate Quality from Preclinical to Commercial with Jackie Klecker

Building Phase-Appropriate Quality from Preclinical to Commercial with Jackie Klecker

January 12, 2026 · 35 min

About this episode

Jackie Klecker discusses building phase-appropriate quality systems in life sciences from preclinical to commercial stages.

Scaling a product from preclinical development to commercial manufacturing is one of the most complex transitions life science teams face—and one of the easiest places to lose time and momentum. In this episode of The Life Science Rundown , host Nick Capman speaks with Jackie Klecker , Executive Vice President of Quality and Development Services at Lifecore Biomedical , about how sponsors and CDMOs can build robust, phase-appropriate quality systems without over-engineering early or under-preparing later. Drawing on decades of experience across pharmaceutical drug products, medical devices, APIs, and biologics, Jackie shares practical guidance on knowledge transfer, risk management, QMS maturity, and regulatory expectations across the U.S. and EU. The conversation focuses on what actually prevents costly delays—and how disciplined communication and documentation make scaling achievable. A few key takeaways: Early quality work should be right-sized , not commercialized prematurely Design space, material variability, and sensitivities must be understood and documented early FMEA works best when it evolves with the product—not when it’s treated as a one-time exercise FDA and EU…

More episodes of The Life Science Rundown

Explore listener stats, chart rankings, contacts and more on the The Life Science Rundown podcast page.